These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 9440703

  • 21. Active site-blocked factors VIIa and IXa differentially inhibit fibrin formation in a human ex vivo thrombosis model.
    Kirchhofer D, Tschopp TB, Baumgartner HR.
    Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1098-106. PubMed ID: 7627702
    [Abstract] [Full Text] [Related]

  • 22. Adenovirus-mediated local expression of human tissue factor pathway inhibitor eliminates shear stress-induced recurrent thrombosis in the injured carotid artery of the rabbit.
    Nishida T, Ueno H, Atsuchi N, Kawano R, Asada Y, Nakahara Y, Kamikubo Yi, Takeshita A, Yasui H.
    Circ Res; 1999 Jun 25; 84(12):1446-52. PubMed ID: 10381897
    [Abstract] [Full Text] [Related]

  • 23. Antithrombotic and antilesion benefits without hemorrhagic risks by inhibiting tissue factor pathway.
    Harker LA, Hanson SR, Wilcox JN, Kelly AB.
    Haemostasis; 1996 Jun 25; 26 Suppl 1():76-82. PubMed ID: 8904178
    [Abstract] [Full Text] [Related]

  • 24. A soluble tissue factor mutant is a selective anticoagulant and antithrombotic agent.
    Kelley RF, Refino CJ, O'Connell MP, Modi N, Sehl P, Lowe D, Pater C, Bunting S.
    Blood; 1997 May 01; 89(9):3219-27. PubMed ID: 9129026
    [Abstract] [Full Text] [Related]

  • 25. Recombinant nematode anticoagulant protein c2 and other inhibitors targeting blood coagulation factor VIIa/tissue factor.
    Lee AY, Vlasuk GP.
    J Intern Med; 2003 Oct 01; 254(4):313-21. PubMed ID: 12974870
    [Abstract] [Full Text] [Related]

  • 26. Pharmacological intervention at disparate sites in the coagulation cascade: comparison of anti-thrombotic efficacy vs bleeding propensity in a rat model of acute arterial thrombosis.
    Szalony JA, Taite BB, Girard TJ, Nicholson NS, LaChance RM.
    J Thromb Thrombolysis; 2002 Oct 01; 14(2):113-21. PubMed ID: 12714830
    [Abstract] [Full Text] [Related]

  • 27. Experimental carotid thrombosis in the guinea pig.
    Roux S, Carteaux JP, Hess P, Falivene L, Clozel JP.
    Thromb Haemost; 1994 Feb 01; 71(2):252-6. PubMed ID: 8191408
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Local application of recombinant active-site inhibited human clotting factor VIIa reduces thrombus weight and improves patency in a rabbit venous thrombosis model.
    Holst J, Kristensen AT, Kristensen HI, Ezban M, Hedner U.
    Eur J Vasc Endovasc Surg; 1998 Jun 01; 15(6):515-20. PubMed ID: 9659887
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Differential effects of endothelin receptor activation on cyclic flow variations in rat mesenteric arteries.
    Fujise K, Stacy L, Beck P, Yeh ET, Chuang A, Brock TA, Willerson JT.
    Circulation; 1997 Nov 18; 96(10):3641-6. PubMed ID: 9396466
    [Abstract] [Full Text] [Related]

  • 33. Nonpeptide factor Xa inhibitors II. Antithrombotic evaluation in a rabbit model of electrically induced carotid artery thrombosis.
    Wong PC, Crain EJ, Knabb RM, Meade RP, Quan ML, Watson CA, Wexler RR, Wright MR, Slee AM.
    J Pharmacol Exp Ther; 2000 Oct 18; 295(1):212-8. PubMed ID: 10991981
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Recombinant human activated factor VII is thrombogenic in a rabbit model of cyclic flow reduction and does not reduce intra-abdominal bleeding.
    Charbonneau S, Girard F, Boudreault D, Ruel M, Blais N, Hardy JF.
    Thromb Haemost; 2007 Feb 18; 97(2):296-303. PubMed ID: 17264960
    [Abstract] [Full Text] [Related]

  • 37. Endogenous tissue factor pathway inhibitor modulates thrombus formation in an in vivo model of rabbit carotid artery stenosis and endothelial injury.
    Ragni M, Golino P, Cirillo P, Scognamiglio A, Piro O, Esposito N, Battaglia C, Botticella F, Ponticelli P, Ramunno L, Chiariello M.
    Circulation; 2000 Jul 04; 102(1):113-7. PubMed ID: 10880423
    [Abstract] [Full Text] [Related]

  • 38. Antithrombotic efficacy of inactivated active site recombinant factor VIIa is shear dependent in human blood.
    Orvim U, Barstad RM, Orning L, Petersen LB, Ezban M, Hedner U, Sakariassen KS.
    Arterioscler Thromb Vasc Biol; 1997 Nov 04; 17(11):3049-56. PubMed ID: 9409292
    [Abstract] [Full Text] [Related]

  • 39. A highly constrained cyclic (S,S)-CDC- peptide is a potent inhibitor of carotid artery thrombosis in rabbits.
    Roussa VD, Stathopoulou EM, Papamichael ND, Englezopoulos CV, Rousouli KI, Trypou P, Moussis V, Tellis CC, Katsouras CS, Tsikaris V, Tselepis AD, Michalis LK.
    Platelets; 2011 Nov 04; 22(5):361-70. PubMed ID: 21158497
    [Abstract] [Full Text] [Related]

  • 40. Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal-regulated kinase activation.
    Cirillo P, Calì G, Golino P, Calabrò P, Forte L, De Rosa S, Pacileo M, Ragni M, Scopacasa F, Nitsch L, Chiariello M.
    Circulation; 2004 Jun 15; 109(23):2911-6. PubMed ID: 15173027
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.